Trials / Completed
CompletedNCT02163434
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- State University of New York at Buffalo · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will compare the effectiveness of gabapentin to metoclopramide for 1 week among 60 women with hyperemesis gravidarum (HG) in this randomized, double-blinded trial. After completion of the 1-week double-blind phase, subjects will be offered open-label gabapentin with rescue metoclopramide until their symptoms no longer require treatment. Enrollment will occur at the University's at Buffalo, of Rochester and of Wisconsin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin | |
| DRUG | Metoclopramide |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2019-10-01
- Completion
- 2019-11-01
- First posted
- 2014-06-13
- Last updated
- 2023-02-14
- Results posted
- 2021-09-27
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02163434. Inclusion in this directory is not an endorsement.